MICHAEL PAPPAS: Open Payments
NPI 1265208904 · APOLLO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 34 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $899 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $168 |
| Inspire Medical Systems, Inc. | 1 | $140 |
| Lilly USA, LLC | 4 | $66 |
| Exact Sciences Corporation | 3 | $56 |
| Amgen Inc. | 3 | $47 |
| Dexcom, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Corcept Therapeutics | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: INSPIRE, UBRELVY, MOUNJARO, VRAYLAR, OTEZLA, Dexcom G6 Transmitter, AIRSUPRA, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
